Literature DB >> 22072722

Persistence and titer changes of rubella virus antibodies in primiparous women who had been vaccinated with strain RA 27/3 in junior high school.

Ching-Chiang Lin1, Chun-Yuh Yang, Yung-Luen Shih, Yang-Yang Huang, Tsung-Han Yang, Jin-Yuan Liang, Chu-Fen Chang, Hsiu-Shu Hsieh, Yeou-Lih Huang.   

Abstract

Taiwan's rubella vaccination program was launched in 1986; each schoolgirl in the third grade of junior high school received one dose of rubella (RA 27/3) vaccine. We reviewed the results of 14,090 prenatal rubella tests for primiparas from three areas of Taiwan during 2002 to 2008 to investigate seronegativity rates and titer changes. In all primiparous women, the average rubella virus seronegativity rate was 6.5% (95% confidence interval [95% CI], 6.1 to 6.9%), and the average rubella virus antibody titer was 65.9 IU/ml (95% CI, 64.7 to 67.1 IU/ml). There were 1,220 women (8.7%) with weakly positive antibody titers (10 to 20 IU/ml). The rubella virus seronegativity rates, which ranged from 5.4 to 9.7%, did not exhibit a linear trend from 9 to 22 years after vaccination (P = 0.201); in contrast, a significant trend appeared in the average rubella virus IgG titer (P = 0.003), dropping from 69.9 IU/ml in the 9th year after vaccination to 54.8 IU/ml in the 22nd year. The mean annual antibody decay rate was -0.77 IU/ml. This study reveals that the level of rubella virus antibodies declined slowly in women of childbearing age who were vaccinated with RA 27/3 at junior high school age. The number of women who were seronegative or had weakly positive antibody titers was still high (15.2%). Therefore, in countries that implement a single-dose regimen in children or teenagers, it should remain an important policy to encourage voluntary immunization in seronegative women and to immunize all postpartum women who are susceptible to rubella virus infection before they leave the hospital.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072722      PMCID: PMC3255950          DOI: 10.1128/CVI.05334-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  22 in total

Review 1.  Measles and rubella in the World Health Organization European region: diversity creates challenges.

Authors:  John S Spika; Steven Wassilak; Richard Pebody; Galina Lipskaya; Sergei Deshevoi; Dalya Guris; Nedret Emiroglu
Journal:  J Infect Dis       Date:  2003-05-15       Impact factor: 5.226

2.  Seroprevalence of rubella among women of childbearing age in Taiwan after nationwide vaccination.

Authors:  Shih-Bin Su; How-Ran Guo
Journal:  Am J Trop Med Hyg       Date:  2002-11       Impact factor: 2.345

3.  Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland.

Authors:  I Davidkin; H Peltola; P Leinikki; M Valle
Journal:  Vaccine       Date:  2000-07-15       Impact factor: 3.641

4.  The epidemiology of rubella on Taiwan. I. Introduction and description of the 1957-1958 epidemic.

Authors:  J T Grayston; J L Gale; R H Watten
Journal:  Int J Epidemiol       Date:  1972       Impact factor: 7.196

5.  Persistence of vaccine-induced immune responses to rubella: comparison with natural infection.

Authors:  D M Horstmann; A Schluederberg; J E Emmons; B K Evans; M F Randolph; W A Andiman
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

6.  Rubella seroepidemiology and estimations of the catch-up immunisation rate and persistence of antibody titers in pregnant women in Taiwan.

Authors:  C-C Lin; C-Y Yang; Y-L Shih; H-W Hsu; T-H Yang; Y-W Cheng; C-F Chang; L-C Hsieh; B-H Chen; C-H Lee; Y-L Huang
Journal:  BJOG       Date:  2011-03-08       Impact factor: 6.531

7.  Mumps and rubella eliminated from Finland.

Authors:  H Peltola; I Davidkin; M Paunio; M Valle; P Leinikki; O P Heinonen
Journal:  JAMA       Date:  2000 Nov 22-29       Impact factor: 56.272

8.  Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets.

Authors:  Anthony Nardone; Annedore Tischer; Nick Andrews; Jo Backhouse; Heidi Theeten; Nina Gatcheva; Marios Zarvou; Bohumir Kriz; Richard G Pebody; Kalman Bartha; Darina O'Flanagan; Dani Cohen; Arnis Duks; Algirdas Griskevicius; Joel Mossong; Christopher Barbara; Adrianna Pistol; Margareta Slaciková; Katarina Prosenc; Kari Johansen; Elizabeth Miller
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

Review 9.  Rubella and congenital rubella syndrome: global update.

Authors:  Susan E Robertson; David A Featherstone; Marta Gacic-Dobo; Bradley S Hersh
Journal:  Rev Panam Salud Publica       Date:  2003-11

10.  Development of the rubella vaccine and vaccination strategy in Japan.

Authors:  Kohji Ueda
Journal:  Vaccine       Date:  2009-05-21       Impact factor: 3.641

View more
  5 in total

1.  Pitfalls of rubella serology while on the brink of elimination: evaluation of national data, Belgium, 2017.

Authors:  Sofie Colman; Kris Vernelen; Bernard China; Dorien Van den Bossche; Laura Cornelissen; Marie-Luce Delforge; Marijke Reynders; Mario Berth; Melissa Depypere; Natasja Van Gasse; Sara Vijgen; Jos Van Acker; An Boel; Elizaveta Padalko
Journal:  Euro Surveill       Date:  2021-05

Review 2.  Does Rubella Cause Autism: A 2015 Reappraisal?

Authors:  Jill Hutton
Journal:  Front Hum Neurosci       Date:  2016-02-01       Impact factor: 3.169

3.  Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.

Authors:  Iana H Haralambieva; Michael J Gibson; Richard B Kennedy; Inna G Ovsyannikova; Nathaniel D Warner; Diane E Grill; Gregory A Poland
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

4.  Rubella immune status of neonates - a window towards seroprevalence among childbearing women.

Authors:  Iris Pejcic; Milica Rankovic Janevski; Aleksandra Knezevic; Djordje Jevtovic; Maja Stanojevic
Journal:  BMC Public Health       Date:  2016-08-19       Impact factor: 3.295

5.  Recent trends in seroprevalence of rubella in Korean women of childbearing age: a cross-sectional study.

Authors:  Rihwa Choi; Yejin Oh; Youngju Oh; Sung Ho Kim; Sang Gon Lee; Eun Hee Lee
Journal:  BMJ Open       Date:  2020-01-02       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.